Paul L. Berns - 17 Feb 2026 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
Title: Chief Executive Officer and Chairman of the Board, Director
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Paul L. Berns
Issuer symbol
NMRA
Transactions as of
17 Feb 2026
Net transactions value
-$34,459
Form type
4
Filing time
19 Feb 2026, 17:05:16 UTC
Previous filing
09 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BERNS PAUL L Title: Chief Executive Officer and Chairman of the Board, Director C/O NEUMORA THERAPEUTICS, INC., 260 ARSENAL WAY, SUITE 1, WATERTOWN /s/ Michael Milligan, as Attorney-in-Fact for Paul L. Berns 19 Feb 2026 0001202769

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Sale $34,459 -9,819 -0.13% $3.51 7,395,185 17 Feb 2026 Direct F1, F2
holding NMRA Common Stock 133,097 17 Feb 2026 See footnote F3
holding NMRA Common Stock 133,097 17 Feb 2026 See footnote F4
holding NMRA Common Stock 133,097 17 Feb 2026 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades in prices ranging from $3.48 to $3.545, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Held by LULU TRUST OF 2024 FBO AB.
F4 Held by LULU TRUST OF 2024 FBO OB.
F5 Held by LULU TRUST OF 2024 FBO HB.

Remarks:

Title: Chief Executive Officer and Chairman of the Board